Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Apr 22.
Published in final edited form as: Alzheimer Dis Assoc Disord. 2016 Jan-Mar;30(1):41–46. doi: 10.1097/WAD.0000000000000096

Determinants of Activity Levels in African Americans with Mild Cognitive Impairment

Barry W Rovner 1, Robin J Casten 2, Benjamin E Leiby 3
PMCID: PMC5911368  NIHMSID: NIHMS959446  PMID: 25811797

Abstract

Engaging in cognitive, social, and physical activities may prevent cognitive decline. In a sample of older African Americans with Mild Cognitive Impairment (N=221), we investigated the cross-sectional relationships between activity levels and participants’ demographic, clinical, and neuropsychological characteristics. The average age of participants was 75.4 years (standard deviation [SD] 7.0); 177 (80.1 %) were women. Participation in cognitive/social activities was positively associated with education, depression, literacy, mobility, instrumental activities of daily living (IADL), verbal learning, and subcomponents of executive function. A linear regression identified IADLs, education, depression, and verbal learning as independent predictors. Participation in physical activities was positively associated with gender, depression, IADLs, and subcomponents of executive function. An ordinal regression identified executive function and depression as independent correlates. These data suggest that unique characteristics are associated with cognitive/social and physical activities in older African Americans with MCI. These characteristics, coupled with low activity levels, may increase the risk of progression from Mild Cognitive Impairment to dementia. Culturally relevant behavioral interventions to reduce cognitive decline in this high risk population are needed.

Keywords: Mild Cognitive Impairment, African Americans, Depression

Introduction

Mild Cognitive Impairment (MCI) is a transition state between normal cognitive aging and dementia that affects 10% to 20% of older persons and predicts progression to dementia, particularly Alzheimer’s disease (AD).13 Older African Americans are more likely to meet criteria for MCI than whites, possibly because comorbid medical problems (e.g., diabetes, hypertension), obstacles to health care, low health literacy, fewer years of education of uncertain quality, and limited economic resources increase their risk.47 These factors also explain why African Americans are diagnosed with AD at more advanced stages than whites, when care is costlier and outcomes are less promising.4,7 Culturally relevant preventive interventions are therefore needed to preserve cognition in older African Americans.

An extensive epidemiologic literature suggests that cognitive, social, and physical activities may prevent cognitive decline in cognitively normal persons.813 Whether engaging in these activities reduces cognitive decline in persons with MCI is uncertain. Some studies suggest that cognitive rehabilitative interventions for persons with MCI improve targeted cognitive functions but few other cognitive domains or activities.1416 Physical and psychosocial interventions also have modest cognitive benefits.1719 Possible mechanisms for these effects may include reduced amyloid deposition, improved cardiovascular and cerebrovascular integrity, better glycemic control, lower blood pressure, and better general physical and mental health. 2022

We are currently conducting a randomized controlled trial to test the efficacy of a behavioral intervention to reduce cognitive decline by increasing activity participation in older African Americans with MCI.23 As part of that research, we are interested in identifying the baseline characteristics of participants who respond best, or less well, to the intervention. One predictor of response may be their baseline level of activity. As the clinical trial is ongoing, no outcome results are yet available. In this cross-sectional study, we investigated the relationship between participation in cognitive, social, and physical activities and participants’ demographic, clinical, and neuropsychological characteristics. We tested the hypothesis that participation in these activities would be associated with education, depression, mobility, various aspects of cognition, and everyday functioning. The results may identify important treatment moderators, and thereby increase the theoretical and translational impact of the clinical trial.

Methods

The methods of this clinical trial have previously been reported.23 Briefly, 221 African Americans were enrolled in a clinical trial testing the efficacy of a behavioral intervention to reduce cognitive decline over 2 years. The inclusion criteria are: 1) self-identified African American race; 2) age over 65 years; and 3) amnestic MCI (single or multiple domain). To meet the latter criterion, participants had self-reported memory decline; preserved general cognition (i.e., Mini Mental Status Examination [MMSE] score over 22); self-reported independence in basic activities of daily living; and scores more than 1.5 standard deviations (SD) below age-, education-, and race-adjusted norms in delayed recall on the Hopkins Verbal Learning Test-Revised (HVLT-R).2426 The exclusion criteria were: 1) Axis I Diagnostic and Statistical Manual-IV psychiatric diagnosis; 2) sensory deficits that precluded neuropsychological testing; 3) reduced life expectancy (given the 2 year follow-up period); and 4) institutional residence. Race-concordant Community Health Workers (CHWs) recruited participants from senior centers, senior high rise apartment buildings, churches, and primary care clinics. To screen for cognitive impairment, the CHWs administered Trial 1 of the HVLT-R (immediate recall) to potentially eligible participants. Recalling fewer than 5 of 12 words was considered screen positive. A previous study reported that the average Trial 1 HVLT-R score for African Americans aged 60–71 years is 4.4 (SD 1.3).26 A total of 1,034 persons were screened and 524 (50.7%) screened positive. For the latter, the CHWs scheduled an in-home visit to obtain informed consent and complete the baseline assessment. Jefferson’s Institutional Review Board approved this approach to contacting, consenting, and evaluating persons for possible research participation. The CHWs obtained the following data at baseline:

Demographic characteristics

These included age, sex, education, marital status, and literacy as measured on the Reading Recognition Subtest of the Wide Range Achievement Test-Version 3 [WRAT-3]).27

Physical health status

Participants reported the presence of chronic medical conditions, mobility (i.e., ability to walk two blocks without help), and medication use. The latter was used to obtain the Chronic Disease Score, which is a weighted score based on current medication use that predicts healthcare utilization and costs.28 Higher scores (transformed into z scores) reflect greater severity of medical comorbidity.

Instrumental activities of daily living (IADL)

This was assessed with the Alzheimer’s Disease Cooperative Study Activities of Daily Living–Prevention Instrument (ADL-PI), which self-rates level of difficulty performing instrumental activities over the past 3 months (e.g., managing medications, handling money, shopping, preparing food).29 Scores range from 0 to 45 with higher scores representing better function.

Depressive symptoms

This was assessed with Geriatric Depression Scale (GDS-15 items), which self-rates depressive symptoms (e.g., depressed mood, loss of interests, hopelessness) as “present’ or “absent” over the past week.30 Scores range from 0 to 15 with higher scores indicating worse depression.

Participation in activities

This was assessed with the Florida Cognitive Activities Scale (FCAS) and the U.S. Health Interview Survey (US-HIS).3133 The FCAS is a 25-item measure of predominantly cognitive and social activities (“cognitive/social”) with known reliability and validity in older African Americans. It rates the frequency of activity participation on a 5 point scale as: “used to do activity but not in past year” (0); “a few times a year” (1); “every couple of months” (2); “a couple times a month” (3); “a few times a week” (4); and “every day” (5). Items include board games, crossword puzzles, reading the newspaper, craft work, home repairs, cooking, and going to church or social clubs. Scores range from 0 to 125, with higher scores indicating more frequent activity participation. The 9-item US-HIS characterizes participation in physical activities (e.g., walking for exercise, dancing, swimming, and biking) as the number of times, and amount of time in minutes, that a person engages in each activity in the previous 2 weeks. Each item is scored as the product of the number of times a person engages in an activity by the number of minutes spent in that activity.

Cognition

This was assessed with the Hopkins Verbal Learning Test-Revised (HVLT-R) and the National Alzheimer’s Coordinating Center’s (NACC) Uniform Data Set (UDS) Neuropsychological Battery.25, 34 The HVLT-R is a word-list learning and memory test that consists of a 12 item-word list presented in 3 consecutive learning trials. The Total Recall score is the sum of the 3 learning trials; scores range from 0 – 36. The Delayed Recall score is the number of correctly recalled words 20 minutes later; scores range from 0 – 12. The UDS Neuropsychological Battery includes the MMSE and tests of immediate and delayed verbal episodic memory (Logical Memory of the Wechsler Memory Scale [WMS-R] – Revised) IA and IIA, respectively); attention (Digit Span, Forwards and Reverse); semantic memory/language (Boston Naming and Category Fluency Test); processing speed/visuospatial ability (WAIS-R Digit Symbol and Trailmaking Test Part A); and various subcomponents of executive function (Trailmaking Test Part B, Digit Span, and Digit Symbol). Participants who met criteria for amnestic MCI and scored below the 7th percentile in a second cognitive domain met criteria for amnestic MCI-Multiple Domain.

Statistical methods

Bivariate comparisons across FCAS-defined activity groups were made using ANOVA for continuous variables and chi square or Fisher’s Exact Test (for expected values less than 5) for categorical variables. A multivariable regression with FCAS score as the dependent variable was conducted, with all baseline variables considered as covariates. For the US-HIS, proportional odds logistic regression was used to estimate bivariate associations between the ordinal dependent variable of US-HIS score grouping and all baseline variables. A multivariable proportional odds model was fit with US-HIS score grouping as the dependent variable and all baseline variables considered as covariates. Both unadjusted and adjusted odds ratios for having higher activity were calculated.

Results

The average age of participants was 75.4 years (standard deviation [SD] 7.0); 177participants (80.1%) were women; and mean years of education was 12.5 (SD 2.6). One hundred seventy six participants (79.6 %) met criteria for amnestic MCI-Multiple Domain and 45 participants (20.4 %) met criteria for amnestic MCI-single domain. Table 1 shows the total sample mean scores and percentile ranks on the various neuropsychological tests. Percentile scores were based on normative scores from the appropriate test manuals, adjusted for age, race, and education.3537 As expected, the lowest scores and percentile ranks were on tests of memory. The higher scores and ranks on tests of semantic memory, language, and executive function suggest that the overall sample was not globally cognitive impaired.

Table 1.

Average Neuropsychological Test Scores of the Study Sample (n = 221)

Mean SD Percentile
MMSE 25.81 2.40 13%
HVLT Total Recall1 14.76 3.46 15%
HVLT Delayed Recall1 1.75 1.83 1–2%
HVLT Learning Curve1 -0.02 1.39 2–3%
Boston Naming Test (15-item) 12.21 2.19 37%
WMS-R Logical Memory A-Immediate2 9.00 3.52 ---
WMS-R Logical Memory A-Delayed2 6.17 3.89 ---
Category Fluency (animals) 12.37 3.55 45%
Trail Making Test, Part A 78.41 34.49 4%
Trail Making Test, Part B 238.49 75.77 23%
WAIS-III Digit Symbol3 31.59 13.29 9%
Digit Span Forwards 7.07 1.88 16%
Digit Span Backwards 4.35 1.50 5%
1

Hopkins Verbal Learning Test

2

Wechsler Memory Scale (mean scores are similar to those reported in persons with MCI).48

3

Wechsler Adult Intelligence Scale

FCAS scores were normally distributed (range 0 to125; median 53; and mean [SD] 54.0 [14.2]. Participants were categorized as having low (i.e., one standard deviation [SD] below the mean), intermediate (i.e., within one SD below or above the mean), or high (i.e., one SD above the mean) levels of activity. Thirty seven participants (16.7%) had low activity levels; 147 (66.5%) had intermediate activity levels; and 37 (16.7%) had high activity levels. Table 2 compares the demographic, clinical, and neuropsychological characteristics of participants by FCAS activity level. The latter was positively associated (i.e., p ≤ 0.05) with education, literacy (WRAT-3 score), mobility, IADL function, GDS score, and HVLT Total Recall, WMS-R Logical Memory IA, Digit Symbol Substitution, and Trailmaking Test Part A and B scores. All variables in Table 2 were included in a linear regression analysis with FCAS scores as the dependent variable. Table 3 shows the regression results, and indicates that IADL function, education, GDS score, and HVLT Total Recall score each contributed independently to cognitive/social activity participation. The model accounted for 25% of the variance.

Table 2.

Demographic and Clinical Characteristics (N = 221) by Cognitive/Social Activity Level (Florida Cognitive Activity Scale)

Variables Low (n = 37) Medium (n = 147) High (n = 37) Statistic df p
Demographic/Psychosocial
Age (mean, SD) 74.3 (7.2) 76.0 (7.2) 74.2 (5.6) F = 1.60 2,218 .204
Female (n, %) 32 (86.5) 116 (78.9) 29 (78.4) X2 = 1.15 2 .564
Education, yrs. (mean, SD)1 11.8 (2.7) 12.5 (2.5) 13.4 (2.6) F = 4.04 2,218 .019
WRAT (mean, SD)2,3 23.3 (7.9) 27.6 (6.8) 28.1 (5.5) F = 6.44 2, 218 .002
GDS score (mean, SD)4,5 5.2 (3.2) 3.2 (3.1) 2.1 (2.1) F =11.2 2, 218 <.001
Physical
 Chronic Disease Score (mean, SD) 4335.6 (4007.5) 4552.5 (4571.3) 3553.2 (2389.7) F = .83 2, 218 .433
 Able to walk 2 blocks without assistance (n, %) 18 (50) 114 (79.2) 29 (78.4) X2 = 13.20 2 .001
 ADL-PI score (mean, SD)6,7 30.8 (6.6) 36.3 (5.3) 38.8 (4.3) F = 22.00 2, 218 <.001
Neurospsycholgocal
 Mini Mental Status Score 25.6 (2.9) 25.8 (2.3) 26.2 (2.3) F = .51 2, 218 .602
 HVLT Total Recall78 13.1 (3.6) 14.8 (3.4) 16.3 (2.9) F =8.23 2, 218 <.001
 HVLT Delayed Recall8 2.1 (1.8) 1.6 (1.8) 1.9 (1.9) F = 1.41 2, 218 .248
 Boston Naming Test 11.6 (2.4) 12.3 (2.2) 12.6 (1.7) F = 2.10 2, 218 .124
 Category Fluency 11.8 (3.7) 12.3 (3.6) 13.2 (3.1) F = 1.49 2, 218 .228
 Trail Making Test, Part A9 91.6 (38.5) 77.4 (33.1) 69.1 (32.7) F = 4.26 2, 218 .015
 Trail Making Test, Part B10 249.7 (73.0 244.6 (73.6) 202.9 (78.9) F = 5.17 2, 218 .006
 Digit Symbol Substitution10 27.8 (13.2) 31.1 (12.7) 37.2 (14.2) F = 5.11 2, 218 .007
 Digit Span - Forward 6.7 (1.9) 7.1 (1.8) 7.2 (2.0) F = .87 2, 218 .420
 Digit-Span - Backward 4.3 (1.5) 4.4 (1.4) 4.4 (1.8) F = .06 2, 218 .940
 Wechsler Memory Scale-R Logical Memory IA9 7.6 (2.7) 9.1(3.7) 10.0 (3.2) F = 4.39 2, 218 .014
 Wechsler Memory Scale-R Logical Memory IIA 5.2 (3.5) 6.2 (4.1) 7.0 (3.3) F = 1.983 2, 218 .140
 Amnestic MCI-multiple domain (n, %) 6 (16.2) 25 (17) 14 (37.8) X2 = 8.38 2 .015
1

The low activity group has fewer years of education than the high activity group.

2

Wide Range Achievement Test; higher scores signify better literacy.

3

The low activity group has significantly lower scores than the middle and high activity groups.

4

Geriatric Depression Scale; higher scores signify worse depression.

5

The low activity group has significantly higher scores than the middle and high activity groups.

6

Alzheimer’s Disease Cooperative Study Activities of Daily Living–Prevention Instrument; higher scores signify better function.

7

All 3 activity groups differ significantly from each other.

8

Hopkins Verbal Learning Test; higher scores signify better memory.

9

Scores for the low activity group are significantly worse than those of the high activity group.

10

Scores for the high activity group are significantly better than scores of the middle and low activity groups.

Table 3.

Regression results: Baseline Variables associated with Florida Cognitive Activity Scale Scores.

Variable Beta p R2

ADL Total Score1 .24 <.001
Years of education .18 .005 25%
GDS2 −.20 .003
HVLT Total Recall3 .16 .01
1

Alzheimer’s Disease Cooperative Study Activities of Daily Living–Prevention Instrument

2

Geriatric Depression Scale score

3

Hopkins Verbal Learning Score

The distribution of US-HIS scores was positively skewed [skewness = 4.7 (.16); kurtosis = 32.3 (.33)], with nearly 20% of the sample (n = 45) reporting no physical activity. The most common activities in which participants engaged were walking for exercise (68.2%), calisthenics or general exercise (44.7%), dancing (18.5%), and gardening or yard work (14.6%). Participants engaged in an average of 5.4 hours (SD 8.4) of physical activity/2 weeks. We divided the sample into three groups: participants who engaged in fewer than 60 minutes of exercise/2 weeks; 61 - 149 minutes/2 weeks; or 150 minutes or more/2 weeks.

Table 4 shows the unadjusted and adjusted odds ratios and confidence intervals for the relationship of participants’ demographic, clinical, and neuropsychological characteristics and US-HIS physical activity. The odds ratios indicate the likelihood of being in a higher physical activity group. The unadjusted analyses show that physical activity was positively associated (i.e., p ≤ 0.05) with male gender, scores on the WRAT, GDS, and chronic disease (CDS), ability to walk two blocks, and IADL performance. Notably, none of the neuropsychological test scores were related to physical activity in the unadjusted analysis. The adjusted analyses, however, indicate that scores on the GDS, Digit Span Backwards, and Trailmaking Test Part B contributed independently to physical activity participation. The 0.90 odds ratio for GDS indicates that every one point increase in GDS score (i.e., worse depression) reduces the odds of being in the higher physical activity group by 10%. The adjusted odds ratios for Trailmaking Test Part B [i.e., 1.05; (95% CI 1.00, 1.09)] and Digit Span Backwards [i.e., 0.80; (95% CI 0.66, 0.99)] suggest that better performance on these tests was associated with lower physical activity, although these relationships may represent a statistical artifact given the absence of significant relationships in the unadjusted analysis.

Table 4.

Ordinal Regression Results Predicting Physical Activity Level (n = 221)1

Variables Unadjusted Proportional OR (CI) p Adjusted Proportional OR (CI) p
Demographic/Psychological
 Age .97 (.94; 1.00) .078 .96 (.92; 1.01) .129
 Female .41 (.22; .77) .006 .50 (.25; 1.02) .057
 Education, yrs 1.07 (.97; 1.18) .190 1.02 (.90; 1.15) .741
 WRAT2 1.04 (1.00; 1.08) .043 1.04 (.99; 1.10) .095
 GDS score3 .87 (.80; .95) .001 .90 (.81; 1.00) .040
Physical
 Chronic Disease Score4 .93 (.86; 99) .027 .97 (.90; 1.04) .349
 Not able to walk 2 blocks .57 (.32; 1.00) .050 .89 (.46; 1.74) .734
 ADL-PI score5 1.07 (1.03; 1.12) .001 1.03 (.98; 1.09) .223
Neuropsychological
 Mini Mental Status Score 1.04 (.94; 1.15) .482 1.01 (.89; 1.16) .861
 HVLT Total Recall6 1.05 (.97, (1.12) .221 1.00 (.92;1.09) .974
 HVLT Delayed Recall6 1.07 (.94; 1.22) .298 1.04 (.89; 1.22) .585
 Boston Naming Test7 1.05 (.94; 1.18) .375 0.96 (.83; 1.10) .535
 Category Fluency8 1.04 (.97; 1.12) .226 1.00 (.93; 1.09) .910
 Trail Making Test, Part A9 .93 (.87; 1.00) .058 .96 (.86; 1.07) .421
 Trail Making Test, Part B9 1.00 (.97; 1.04) .813 1.05 (1.00; 1.09) .049
 Digit Symbol Substitution10 1.15 (.96; 1.39) .135 1.02 (.78; 1.34) .866
 Digit Span – Forward11 .99 (.87; 1.12) .849 1.02 (.87; 1.19) .832
 Digit-Span – Backward11 .86 (.73; 1.01) .066 .80 (.66; .99) .037
 Wechsler Memory Scale-R Logical Memory IA12 1.02 (.95; 1.09) .640 .99 (.88; 1.11) .895
 Wechsler Memory Scale-R Logical Memory IIA12 1.05 (.99; 1.12) .129 1.01 (.91; 1.13) .838
1

The low group engaged in 0 to 59 minutes of activity in past 2 weeks (coded 1), the middle group engaged in 60 to 149 minutes (coded 2), and the high group engaged in more than 150 minutes (coded 3). Odds ratios are for odds of having higher activity. Deviance = 434.43, p = .176; Pseudo R2 = .175.

2

Wide Range Achievement Test

3

Geriatric Depression Scale

4

Expressed in increments of $1,000.

5

Alzheimer’s Disease Cooperative Study Activities of Daily Living–Prevention Instrument; higher scores signify better function.

6

Hopkins Verbal Learning Test

7

Scored as the number of correctly identified pictures.

8

Scored as the number of animals named in 60 seconds.

9

Scored as the number of seconds for task completion; expressed in 10 second increments.

10

Scored as the number of correct symbols; expressed in 10 symbol increments.

11

Scored as the number of correctly recalled sequences.

12

Scored as the number of correctly recalled story components.

Discussion

We found that unique demographic, clinical, and neuropsychological characteristics were associated with participation in cognitive/social and physical activities in older African Americans with MCI. All participants had clinically meaningful deficits in memory and most had deficits in other cognitive domains. The participants were not, however, globally cognitively impaired or dependent in basic activities of daily living, and therefore did not meet criteria for dementia.42 Cognitive/social activities were independently associated with instrumental activities of daily living, education, depression, and verbal learning. Physical activities were independently associated with depression. All of these factors are known to contribute to the risk of progression from MCI to dementia, and their association with low activity levels may magnify that risk. In fact, low activity levels may represent an early sign of progression in this sample.3841

The results of this study must be understood in the context of the study’s limitations. The participants were recruited from the community and primary care clinics and enrolled in a randomized controlled trial. These characteristics limit generalizability. We conducted many statistical comparisons and thus there is a risk of finding statistically significant relationships by chance that are not clinically meaningful. Our use of the HVLT to identify potential participants constrained test scores, but HVLT Total Recall scores had substantial variability and range. By contrast, Delayed Recall scores were uniformly low as expected, given the study eligibility criteria. We relied on self-reports of functional abilities and activity levels, which may be biased by faulty recall. Some studies suggest, however, that individuals with MCI can provide accurate appraisals of their functional abilities.43 We did not assess some variables which likely relate to activity participation, such as pain, personality traits (e.g., extroversion), access to transportation, and social support, and we used different metrics to rate participation in cognitive/social and physical activities (i.e., number of occasions and number of minutes, respectively). The FCAS and the US-HIS target different activity domains, however. Most FCAS activities are cognitive and social in nature although some FCAS activities (e.g., walking with a friend) require physical activity. The US-HIS more clearly assesses physical activity. Previous studies have noted the difficulty of deriving pure activity classifications; Schinka et al (2005) discuss this issue extensively.44,45 Despite these limitations, our results provide new insights into the determinants of activity participation in this unique sample of older African Americans.

Depressive symptoms were common to low participation in cognitive/social as well as physical activities. Loss of interest, anhedonia, and anergia diminish motivation to pursue many different types of activities and, in persons with MCI, amplify the effects of apathy, which is the most frequently occurring behavioral symptom of MCI.46 Whether depression is a risk factor for or prodromal sign of dementia is uncertain but depression adds to apathy to impede activity engagement, and may accelerate progression to dementia.

The bivariate analyses for cognitive/social activities revealed positive associations with various aspects of executive function, including attention, cognitive flexibility, perceptual-scanning skills, and processing speed. These subcomponents of executive function were not independent predictors of cognitive/social activity, however, after controlling for HVLT Total Recall. The latter involves both learning, an indicator of hippocampal function, and working memory, a prefrontal executive function. To the extent that Total Recall recruits the latter, and to the extent that cognitive/social activities depend on planning, initiating, and sustaining activity, then worse performance on Total Recall may understandably be linked to lower levels of participation in these types of activities. Moreover, as a sensitive indicator of Alzheimer’s disease pathology, worse Total Recall may be a proxy for more pervasive underlying disease.24, 47

Education was also associated with cognitive/social activity levels. Persons with less education and low literacy have less opportunity to pursue cognitive and leisure activities due to financial and intellectual limitations and, on that basis, may be at higher risk for dementia.10, 48 Literacy, as an indicator of quality of education, may provide a more precise indicator of cognitive reserve than years of education, and determine whether someone with underlying brain pathology expresses symptoms of dementia.49

We also found that performance of instrumental activities of daily living was independently associated with cognitive/social activity levels. Persons with MCI often have difficulty with or take longer completing such higher order activities (e.g., traveling, managing finances, and taking medications) and these difficulties increase the risk of dementia.41, 50

Regarding physical activity participation, the unadjusted analyses revealed positive associations with depression, gender, literacy, physical functioning, and IADLs but no association with neuropsychological test performance. The latter finding suggests that cognitive function per se in this sample of older African Americans with MCI is unrelated to physical activities. Sturman et al (2005), using the same instrument we used to assess physical activity participation, and some of the same neuropsychological tests, in a sample of older persons (61.1% African American), similarly found no association between physical activity participation and neuropsychological test performance.33 They hypothesized that the absence of an independent relationship may reflect the moderately low levels of physical activity in older urban populations.

To our knowledge, no studies similar to ours have examined relationships between activity levels and demographic, personal, and cognitive characteristics of older persons with MCI. Our results are consistent with studies that have examined these relationships in representative populations of older persons. Dotson et al (2008), studying activity participation using the FCAS in a large community sample of older African Americans, found small negative correlations between higher activity levels and age and depressive symptoms, and moderate positive correlations with years of education and overall cognition, memory, and executive function.31 Gow et al (2012) and Wilson et al (2003) found participation in cognitive, leisure, or physical activity was associated with higher levels of cognitive ability, which reflected prior ability and more years of education.8, 48 Together these results suggest both a protective effect of activity on cognition and a facilitative effect of pre-existing cognitive strengths on later activity levels. The converse, as we found, is that low activity participation reflects deficits in mood, memory, executive function, education, and everyday functioning, which represent five unique domains of mental and physical life. These characteristics may moderate treatment outcomes in the clinical trial we are now conducting, and identify participants who respond best, because the intervention reverses activity loss in participants at greatest risk, or who respond less well because they have more advanced disease.

The mechanism by which activity participation may be neuroprotective and reduce cognitive decline, if it does, in persons with MCI, is unknown. Older African Americans, however, comprise one of the fastest growing minority groups in the United States and nearly 25% have MCI.4, 51 These demographic and clinical realities, coupled with the uncertain efficacy and safety of current investigational medications for Alzheimer’s disease and their limited accessibility to older African Americans, necessitate culturally relevant behavioral interventions to prevent cognitive decline in this high risk population.52

Acknowledgments

Source of Funding: This research is supported by grant 1R01AG035025-01A1 from the National Institute on Aging. ClinicalTrials.gov Identifier: NCT01299766

Footnotes

Conflicts of Interest: No disclosures to report.

Contributor Information

Barry W. Rovner, Departments of Neurology and Psychiatry, Sidney Kimmel Jefferson Medical College at Thomas Jefferson University, Philadelphia, Pa 19107.

Robin J. Casten, Department of Psychiatry and Human Behavior, Sidney Kimmel Jefferson Medical College at Thomas Jefferson University, Philadelphia, Pa 19107.

Benjamin E. Leiby, Division of Biostatistics, Department of Pharmacology and Experimental Therapeutics, Sidney Kimmel Jefferson Medical College at Thomas Jefferson University, Philadelphia, PA 19107.

References

  • 1.Petersen RC, Roberts RO, Knopman DS, et al. Mild cognitive impairment: ten years later. Arch Neurol. 2009;66:1447–1455. doi: 10.1001/archneurol.2009.266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Plassman BL, Langa KM, Fisher GG, et al. Prevalence of cognitive impairment without dementia in the United States. Ann Intern Med. 2008;148:427–434. doi: 10.7326/0003-4819-148-6-200803180-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Farias ST, Mungas D, Reed B, Harvey D, DeCarli C. Progression of mild cognitive impairment to dementia in clinic-vs community-based cohorts. Arch Neurol. 2009;66:1151–1157. doi: 10.1001/archneurol.2009.106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Alzheimer’s Association. 2010 Alzheimer’s disease facts and figures. Alzheimers Dement. 2010;6(2):158–194. doi: 10.1016/j.jalz.2010.01.009. [DOI] [PubMed] [Google Scholar]
  • 5.Unverzagt FW, Gao S, Lane KA, et al. Mild cognitive dysfunction: An epidemiological perspective with an emphasis on African Americans. J Geriatr Psychiatry Neurol. 2007;20:215–226. doi: 10.1177/0891988707308804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Lilienfeld DE, Perl DP. Projected neurodegenerative disease mortality among minorities in the United States, 1990–2040. Neuroepidemiology. 1994;13:179–186. doi: 10.1159/000110377. [DOI] [PubMed] [Google Scholar]
  • 7.Cooper C, Tandy AR, Balamurali TBS, et al. A systematic review and meta-analysis of ethnic differences in use of dementia treatment, care, and research. Am J Geriatr Psychiatry. 2010;18:193–203. doi: 10.1097/JGP.0b013e3181bf9caf. [DOI] [PubMed] [Google Scholar]
  • 8.Gow AJ, Mortensen EL, Avlund K. Activity participation and cognitive aging from age 50 to 80 in the Glostrup 1914 cohort. J Am Geriatr Soc. 2012;60:1831–1838. doi: 10.1111/j.1532-5415.2012.04168.x. [DOI] [PubMed] [Google Scholar]
  • 9.Hamer M, Chida Y. Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence. Psychological Medicine. 2009;39:3–11. doi: 10.1017/S0033291708003681. [DOI] [PubMed] [Google Scholar]
  • 10.Verghese J, LeValley A, Derby C, Kuslansky G, Katz M, Hall C, et al. Leisure activities and the risk of amnestic mild cognitive impairment in the elderly. Neurology. 2006;66:821–827. doi: 10.1212/01.wnl.0000202520.68987.48. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Larson EB. Prospects for delaying the rising tide of worldwide, late-life dementias. International Psychogeriatrics. 2010;22(8):1196–1202. doi: 10.1017/S1041610210001080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Middleton LE, Yaffe K. Promising strategies for the prevention of dementia. Arch Neurol. 2009;66(10):1210–1215. doi: 10.1001/archneurol.2009.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Fratiglioni L, Paillard-Borg S, Winblad B. An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol. 2004;3:343–353. doi: 10.1016/S1474-4422(04)00767-7. [DOI] [PubMed] [Google Scholar]
  • 14.Greenaway MC, Duncan NL, Smith GE. The memory support system for mild cognitive impairment: Randomized trial of a cognitive rehabilitation intervention. Int J Geriatr Psychiatry. 2013;28(4):402–409. doi: 10.1002/gps.3838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Stott J, Spector A. Review of the effectiveness of memory interventions in mild cognitive impairment (MCI) International Psychogeriatrics. 2011;23:526–538. doi: 10.1017/S1041610210001973. [DOI] [PubMed] [Google Scholar]
  • 16.Vidovich MR, Lautenschlager NT, Flicker L, Clare L, McCaul K, Almeida OP. The PACE study: a randomized clinical trial of cognitive activity strategy training for older people with mild cognitive impairment. Am J Geriatr Psychiatry. 2014 doi: 10.1016/j.jagp.2014.04.002. (in press). http://dx.doi.org/10.1016/j.jagp.2014.04.002. [DOI] [PubMed]
  • 17.Lautenschlager NT, Cox KL, Flicker L, Foster JK, van Bockxmeer FM, Xiao J, Greenop KR, et al. Effect of physical activity on cognitive function in older adults at risk for alzheimer disease: a randomized trial. JAMA. 2008;300(9):1027–1037. doi: 10.1001/jama.300.9.1027. [DOI] [PubMed] [Google Scholar]
  • 18.Baker LD, Frank LL, Foster-Schubert K, Green PS, Wilkinson CW, McTiernan A. Effects of aerobic exercise on mild cognitive impairment: A controlled trial. Arch Neurol. 2010;67(1):71–79. doi: 10.1001/archneurol.2009.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Barnes DE, Santos-Modesitt W, Poelke G, et al. The Mental Activity and eXercise (MAX) trial: a randomized controlled trial to enhance cognitive function in older adults. JAMA Intern Med. 2013;173(9):797–804. doi: 10.1001/jamainternmed.2013.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Valenzuela M, Sachdev P. Brain reserve and dementia: A systematic review. Psychol Med. 2006;36:441–454. doi: 10.1017/S0033291705006264. [DOI] [PubMed] [Google Scholar]
  • 21.Landau SM, Marks SM, Mormino EC, et al. Association of lifetime cognitive engagement and low beta-amyloid deposition. Arch Neurol. 2012;69(5):623–629. doi: 10.1001/archneurol.2011.2748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Daviglus ML, Plassman BL, Pirzada A, et al. Risk factors and preventive interventions for Alzheimer disease: State of the science. Arch Neurol. 2011;68:1185–1190. doi: 10.1001/archneurol.2011.100. [DOI] [PubMed] [Google Scholar]
  • 23.Rovner BW, Casten RJ, Hegel MT, et al. Preventing cognitive decline in older African Americans with mild cognitive impairment: Design and methods of a randomized clinical trial. Contemporary Clinical Trials. 2012;33:712–720. doi: 10.1016/j.cct.2012.02.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):270–279. doi: 10.1016/j.jalz.2011.03.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Benedict RHB, Brandt J. Manual: Hopkins verbal learning test-revised/Brief visuospatial memory test-revised. Lutz, FL: Psychological Assessment Resources; 1998. [Google Scholar]
  • 26.Friedman M, Schinka J, Mortimer J, et al. Hopkins verbal learning test revised: norms for elderly African-Americans. The Clinical Neuropsychologist. 2002;16:356–372. doi: 10.1076/clin.16.3.356.13857. [DOI] [PubMed] [Google Scholar]
  • 27.Wilkinson GS. Wide-Range Achievement Test. 3. Wilmington, DE: Wide-Range, Inc; 1993. [Google Scholar]
  • 28.Clark DO, Von Korff M, Saunders K, et al. A chronic disease score with empirically derived weights. Medical Care. 1995;33:783–795. doi: 10.1097/00005650-199508000-00004. [DOI] [PubMed] [Google Scholar]
  • 29.Galasko G, Bennett D, Sano M, et al. ADCS prevention instrument project: assessment of instrumental activities of daily living for community-dwelling elderly individuals in dementia prevention clinical trials. Alzheimer Dis & Assoc Disord. 2006;20:S152–S169. doi: 10.1097/01.wad.0000213873.25053.2b. [DOI] [PubMed] [Google Scholar]
  • 30.Yesavage JA. Geriatric Depression Scale. Psychopharmacol Bull. 1988;24:709–711. [PubMed] [Google Scholar]
  • 31.Dotson VM, Schinka JA, Brown LM, et al. Characteristics of the Florida Cognitive Activities Scale in older African Americans. Assessment. 2008;15:72. doi: 10.1177/1073191107307509. [DOI] [PubMed] [Google Scholar]
  • 32.Schinka JA, McBride A, Vanderploeg RD, Tennyson K, Borenstein AR, Mortimer JA. Florida Cognitive Activities Scale: Initial development and validation. J Int Neuropsychol Soc. 2005;11:108–116. doi: 10.1017/S1355617705050125. [DOI] [PubMed] [Google Scholar]
  • 33.Sturman MT, Morris MC, Mendes de Leon C, et al. Physical activity, cognitive activity, and cognitive decline in a biracial community population. Arch Neurol. 2005;62:1750–1754. doi: 10.1001/archneur.62.11.1750. [DOI] [PubMed] [Google Scholar]
  • 34.Morris J, Weintraub S, Chui H, et al. The Uniform Data Set (UDS): Clinical and cognitive variables and descriptive data from Alzheimer’s disease centers. Alzheimer Dis Assoc Disord. 2006;20:210–216. doi: 10.1097/01.wad.0000213865.09806.92. [DOI] [PubMed] [Google Scholar]
  • 35.Lucas JA, Invik RJ, Smith GE, Ferman TJ, Willis FB, et al. Mayo’s older African-American’s normative studies: Norms for Boston naming test, controlled oral word association, category fluency, animal naming, token test, WRAT-3 reading, trail making test, stroop test, and judgment of line orientation. The Clinical Neuropsychologist. 2005;19:243–269. doi: 10.1080/13854040590945337. [DOI] [PubMed] [Google Scholar]
  • 36.Heaton RK, Miller SW, Taylor MJ, Grant I. Revised comprehensive norms for an expanded Halstead–Reitan Battery: Demographically adjusted neuropsychological norms for African American and Caucasian adults. Psychological Assessment Resources, Inc; Lutz, FL: 2004. [Google Scholar]
  • 37.Wechsler D. WAIS-III administration and scoring manual. San Antonio, TX: Psychological Corporation; 1997. [Google Scholar]
  • 38.Houde M, Bergman H, Whitehead V, et al. A predictive depression pattern in mild cognitive impairment. Int J Geriatr Psychiatry. 2008;23:1028–1033. doi: 10.1002/gps.2028. [DOI] [PubMed] [Google Scholar]
  • 39.Manly JJ, Byrd D, Touradji P, et al. Literacy and cognitive change among ethnically diverse elders. Int J Psycho. 2004;39:47–60. [Google Scholar]
  • 40.Dickerson BC, Sperling RA, Hyman BT, et al. Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment. Arch Gen Psychiatry. 2007;64:1443–1450. doi: 10.1001/archpsyc.64.12.1443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Farias ST, Mungas D, Reed BR, et al. Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. Arch Neurol. 2009;66:1151–1157. doi: 10.1001/archneurol.2009.106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:263–269. doi: 10.1016/j.jalz.2011.03.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Farias ST, Mungas D, Jagust W. Degree of discrepancy between self and other-reported everyday functioning by cognitive status: dementia, mild cognitive impairment, and healthy elders. Int J Geriatr Psychiatry. 2005;20:827–834. doi: 10.1002/gps.1367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Akbaraly TN, Portet F, Fustinoni S, et al. Leisure activities and the risk of dementia in the elderly: Results from the Three-City Study. Neurology. 2009;73:854–861. doi: 10.1212/WNL.0b013e3181b7849b. [DOI] [PubMed] [Google Scholar]
  • 45.Schinka JA, McBride A, Vanderploeg RD, Tennyson K, Borenstein AR, Mortimer JA. Florida Cognitive Activities Scale: Initial development and validation. J Int Neuropsychol Soc. 2005;11:108–116. doi: 10.1017/S1355617705050125. [DOI] [PubMed] [Google Scholar]
  • 46.Geda YE, Roberts RO, Knopman DS, et al. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging. Arch Gen Psychiatry. 2008;65:1193–1198. doi: 10.1001/archpsyc.65.10.1193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.De Jager CA, Hogervorst E, Combrinck M, et al. Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer’s disease. Psychological Medicine. 2003;3:1039–1050. doi: 10.1017/s0033291703008031. [DOI] [PubMed] [Google Scholar]
  • 48.Wilson RS, Barnes LL, Bennett DA. Assessment of lifetime participation in cognitively stimulating activities. J Clin Exp Neuropsych. 2003;25:634–642. doi: 10.1076/jcen.25.5.634.14572. [DOI] [PubMed] [Google Scholar]
  • 49.Jefferson AL, Gibbons LE, Rentz DM, et al. A life course model of cognitive activities, socioeconomic status, education, reading ability, and cognition. J Am Geriatr Soc. 2011;59:1403–1411. doi: 10.1111/j.1532-5415.2011.03499.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Hughes TF, Chang CCH, Bilt JV, et al. Mild cognitive deficits and everyday functioning among older adults in the community: The Monongahela-Youghiogheny Healthy Aging Team Study. Am J Geriatr Psychiatry. 2012;20:836–844. doi: 10.1097/JGP.0b013e3182423961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Unverzagt FW, Gao S, Baiyewu O, et al. Prevalence of cognitive impairment: Data from the Indianapolis study of health and aging. Neurology. 2001;57:1655–1662. doi: 10.1212/wnl.57.9.1655. [DOI] [PubMed] [Google Scholar]
  • 52.Chin AL, Negashm S, Hamilton R. Diversity and disparity in dementia: the impact of ethnoracial differences in Alzheimer disease. Alzheimer Dis Assoc Disord. 2011;25:187–195. doi: 10.1097/WAD.0b013e318211c6c9. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES